Abaxis, Inc. (Abaxis) develops, manufactures, markets and sells portable blood analysis systems that are used in a range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. The Company provides veterinary reference laboratory diagnostic and consulting services for veterinarians. The Company operates in two segments, including the medical market and the veterinary market. The medical market and the veterinary market are based on the diagnostic products sold and services provided by market and customer group. The Company’s product and service offerings include VetScan Point-of-Care Blood Chemistry Instruments, VetScan Profiles, VSpro Specialty Analyzers and Consumables, and i-STAT Instruments and Consumables. Abaxis Europe GmbH, the Company’s wholly owned subsidiary in Griesheim, Germany, markets, promotes and distributes diagnostic systems for medical and veterinary uses in the European market.